Maksim S. Abramovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maksim S. Abramovich has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Albertovich Shtil
Blokhin National Medical Research Center of Oncology, Russia
3 shared publications - Elena Kimovna Beloglazkina
Lomonosov Moscow State University, Moscow, Russia, Russia
3 shared publications - Elena S. Barskaya
Lomonosov Moscow State University,Moscow,Russia, Russia
3 shared publications - Albina S. Petrova
Institute of Medicine, RUDN University, 6 Miklukho-Maklaya Street, Moscow 117198, Russia
2 shared publications - Alexander Sergeevich Dubenskiy
Geological Institute of the Russian Academy of Sciences, Pyzhevsky lane 7, 119017, Moscow, Russia
2 shared publications - Anna A. Moiseeva
Department of Chemistry, Moscow State University, 1/3 Leninskie Gory, Moscow 119991, Russia
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by MDPI AG in Preprints.org
Aminoalkyl-Substituted 2-Hetarylimidazophenazines: Synthesis, DNA Binding and Cytotoxicity
A series of ethylamino- and propylamino-substituted 2-(pyridin-2-yl)imidazophenazines bearing various tertiary amine moieties, as well as a series of 2-hetarylimidazophenazines with N,N-diethylethan-1-amine moiety, were synthesized via the reaction of phenazine-2,3-diamine with heterocyclic aldehydes followed by alkylation with chloro-substituted alkylamines. In a study on HCT116, K562 and Kelly cells compounds containing N-methylindole, 2-chloroquinoline, and N-phenylpyrrole moieties exhibited the highest cytotoxicity. The values of binding constants with G-quadruplexes tel22, c-Myc for the leader compounds, determined by the method of fluorescence spectroscopy, were within the order of 105-106 M-1.
- 27 October 2026
- Published by MDPI AG in Preprints.org
Open AccessAminoalkyl-Substituted 2-Hetarylimidazophenazines: Synthesis, DNA Binding and Cytotoxicity
A series of ethylamino- and propylamino-substituted 2-(pyridin-2-yl)imidazophenazines bearing various tertiary amine moieties, as well as a series of 2-hetarylimidazophenazines with N,N-diethylethan-1-amine moiety, were synthesized via the reaction of phenazine-2,3-diamine with heterocyclic aldehydes followed by alkylation with chloro-substituted alkylamines. In a study on HCT116, K562 and Kelly cells compounds containing N-methylindole, 2-chloroquinoline, and N-phenylpyrrole moieties exhibited the highest cytotoxicity. The values of binding constants with G-quadruplexes tel22, c-Myc for the leader compounds, determined by the method of fluorescence spectroscopy, were within the order of 105-106 M-1.
- Open Access
- 19 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (6) , 2800
The Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow
Copper–organic compounds are being investigated as antitumor candidates. Besides their efficacy as cytotoxic agents alone, the oxidative potential of electrochemical Cu2+-to-Cu1+ transition emerges as an attractive approach for elimination of tumor cells otherwise resistant to chemotherapy. To minimize side effects of the potent oxidative burst upon Cu(II) reduction, the metal cations should be delivered to the tumor site. Taking advantage of the ability of bisphosphonates to accumulate in the bone, we synthesized a Cu(II) complex of zoledronic acid (ZA), an FDA-approved drug for prevention of bone destruction. The CuZA complex obtained upon precipitation of ZA and different copper salts (sulfate, chloride or perchlorate) were structurally identical, consisting of two organic moieties coordinated by three metal cations. Combined treatment with water-soluble formulations of CuZA and cysteine triggered rapid death in human cell lines. This effect was achievable with non-toxic concentrations of CuZA and cysteine alone. Importantly, the K562 chronic myelogenous leukemia cells that demonstrated an attenuated response to the 3d generation Bcr-Abl tyrosine kinase inhibitor in the medium conditioned by bone marrow-derived fibroblasts, were readily killed by CuZA–cysteine combination. Thus, oxidative burst upon metal reduction in CuZA complexes emerges as a promising method of eradication of tumor cells in the bone microenvironment.
- 19 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (6) , 2800
Open AccessThe Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow
Copper–organic compounds are being investigated as antitumor candidates. Besides their efficacy as cytotoxic agents alone, the oxidative potential of electrochemical Cu2+-to-Cu1+ transition emerges as an attractive approach for elimination of tumor cells otherwise resistant to chemotherapy. To minimize side effects of the potent oxidative burst upon Cu(II) reduction, the metal cations should be delivered to the tumor site. Taking advantage of the ability of bisphosphonates to accumulate in the bone, we synthesized a Cu(II) complex of zoledronic acid (ZA), an FDA-approved drug for prevention of bone destruction. The CuZA complex obtained upon precipitation of ZA and different copper salts (sulfate, chloride or perchlorate) were structurally identical, consisting of two organic moieties coordinated by three metal cations. Combined treatment with water-soluble formulations of CuZA and cysteine triggered rapid death in human cell lines. This effect was achievable with non-toxic concentrations of CuZA and cysteine alone. Importantly, the K562 chronic myelogenous leukemia cells that demonstrated an attenuated response to the 3d generation Bcr-Abl tyrosine kinase inhibitor in the medium conditioned by bone marrow-derived fibroblasts, were readily killed by CuZA–cysteine combination. Thus, oxidative burst upon metal reduction in CuZA complexes emerges as a promising method of eradication of tumor cells in the bone microenvironment.
- 9 February 2026
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (2) , 10
Сopper(II) Complex with a Hybrid Molecule Containing Pyridylbenzothiazole and Catechol Fragments without Catechol Coordination
A new hybrid organic ligand with 2-(2-pyridyl)benzothiazoles and catechol fragments was synthesized and studied in the complexation reaction with copper(II) chloride. Synthesis conditions that allow for obtaining a complex in which copper coordination is carried out by the pyridylbenzothiazole fragment, and the catechol fragment does not participate in the coordination, have been determined. To find the possibility and optimal conditions for a complex without coordination of catechol formation, DFT calculation data were used. The structure of the obtained coordination compound with LCuCl2 composition was established using as elemental analysis, UV-Vis spectroscopy, cyclic voltammetry and total X-ray scattering with pair distribution function analysis. Measurement of cytotoxicity and the ability to reactive oxygen species (ROS) generation for synthesized complex on MCF-7 cell lines demonstrated reasonable cytotoxicity of 5 µМ, not associated with ROS formation.
- 9 February 2026
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (2) , 10
Сopper(II) Complex with a Hybrid Molecule Containing Pyridylbenzothiazole and Catechol Fragments without Catechol Coordination
A new hybrid organic ligand with 2-(2-pyridyl)benzothiazoles and catechol fragments was synthesized and studied in the complexation reaction with copper(II) chloride. Synthesis conditions that allow for obtaining a complex in which copper coordination is carried out by the pyridylbenzothiazole fragment, and the catechol fragment does not participate in the coordination, have been determined. To find the possibility and optimal conditions for a complex without coordination of catechol formation, DFT calculation data were used. The structure of the obtained coordination compound with LCuCl2 composition was established using as elemental analysis, UV-Vis spectroscopy, cyclic voltammetry and total X-ray scattering with pair distribution function analysis. Measurement of cytotoxicity and the ability to reactive oxygen species (ROS) generation for synthesized complex on MCF-7 cell lines demonstrated reasonable cytotoxicity of 5 µМ, not associated with ROS formation.
- Open Access
- 15 January 2026
- Published by MDPI AG in Preprints.org
New Complexes of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow
Copper-organic compounds are being investigated as antitumor candidates. Besides their efficacy as cytotoxic agents alone, the oxidative potential of electrochemical Cu2+-to-Cu1+ transition emerges as an attractive approach for elimination of tumor cells otherwise resistant to chemotherapy. To minimize side effects of the potent oxidative burst upon Cu(II) reduction, the metal cations should be delivered to the tumor site. Taking advantage of the ability of bisphosphonates to accumulate in the bone, we synthesized Cu(II) complexes of zoledronic acid (ZA), an FDA-approved drug for prevention of bone destruction. New CuZA complexes obtained upon precipitation of ZA and different copper salts were structurally identical, consisting of two organic moieties coordinated by three metal cations. Combined treatment with water-soluble formulations of CuZA and cysteine triggered rapid death in human cell lines. This effect was achievable with non-toxic concentrations of CuZA and cysteine alone. Importantly, the K562 chronic myelogenous leukemia cells that demonstrated an attenuated response to the 3d generation Bcr-Abl tyrosine kinase inhibitor in the medium conditioned by bone marrow-derived fibroblasts, were readily killed by CuZA-cysteine combination. Thus, oxidative burst upon metal reduction in CuZA complexes emerges as a promising method of eradication of tumor cells in the bone microenvironment.
- 15 January 2026
- Published by MDPI AG in Preprints.org
Open AccessNew Complexes of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow
Copper-organic compounds are being investigated as antitumor candidates. Besides their efficacy as cytotoxic agents alone, the oxidative potential of electrochemical Cu2+-to-Cu1+ transition emerges as an attractive approach for elimination of tumor cells otherwise resistant to chemotherapy. To minimize side effects of the potent oxidative burst upon Cu(II) reduction, the metal cations should be delivered to the tumor site. Taking advantage of the ability of bisphosphonates to accumulate in the bone, we synthesized Cu(II) complexes of zoledronic acid (ZA), an FDA-approved drug for prevention of bone destruction. New CuZA complexes obtained upon precipitation of ZA and different copper salts were structurally identical, consisting of two organic moieties coordinated by three metal cations. Combined treatment with water-soluble formulations of CuZA and cysteine triggered rapid death in human cell lines. This effect was achievable with non-toxic concentrations of CuZA and cysteine alone. Importantly, the K562 chronic myelogenous leukemia cells that demonstrated an attenuated response to the 3d generation Bcr-Abl tyrosine kinase inhibitor in the medium conditioned by bone marrow-derived fibroblasts, were readily killed by CuZA-cysteine combination. Thus, oxidative burst upon metal reduction in CuZA complexes emerges as a promising method of eradication of tumor cells in the bone microenvironment.